Poxvirus-based vector systems and the potential for multi-valent and multi-pathogen vaccines-Reference-Cited by-同舟云学术

Poxvirus-based vector systems and the potential for multi-valent and multi-pathogen vaccines

Published:2018-10-03 Issue:10 Volume:17 Page:925-934
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Prow Natalie A.¹²,Jimenez Martinez Rocio¹,Hayball John D.³,Howley Paul M.⁴,Suhrbier Andreas¹²

Affiliation:

1. Inflammation Biology, QIMR Berghofer Medical Research Institute, Brisbane, Australia

2. Inflammation Biology, Australian Infectious Disease Research Centre, Brisbane, Australia

3. Experimental Therapeutics Laboratory, School of Pharmacy & Medical Sciences, University of South Australia Cancer Research Institute, Adelaide, Australia

4. Inflammation Biology, Sementis Ltd, Berwick, Australia

Funder

Principal Research Fellowship

Advance Queensland Research Fellowship

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2018.1522255

Reference117 articles.

1. Vaccinia virus vaccines: Past, present and future

2. Vaccinia Virus Natural Infections in Brazil: The Good, the Bad, and the Ugly

3. Duration of Humoral Immunity to Common Viral and Vaccine Antigens

4. Smallpox Vaccine: The Good, the Bad, and the Ugly

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements, challenges, and future perspectives in developing feline herpesvirus 1 as a vaccine vector;Frontiers in Immunology;2024-09-12

2. Comparison of preclinical efficacy of immunotherapies against HPV-induced cancers;Expert Review of Vaccines;2024-07-08

3. Current Status of Poultry Recombinant Virus Vector Vaccine Development;Vaccines;2024-06-06

4. Generating prophylactic immunity against arboviruses in vertebrates and invertebrates;Nature Reviews Immunology;2024-04-03

5. Construction of recombinant pseudorabies virus expressing PCV2 Cap, PCV3 Cap, and IL-4: investigation of their biological characteristics and immunogenicity;Frontiers in Immunology;2024-03-20